embedded imagein which L is sulfur, sulfoxide, oxygen or methylene, and a compound of formula: embedded imagein which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compounds (and their conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, are non-phosphorylated, are redox-stable in vivo, are characterized by an IC50 in vivo of less than about 4.0 μM with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, have a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates."/> Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
首页> 外国专利> Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

机译:SH2结构域与靶蛋白结合的氧化还原稳定的非磷酸化环肽抑制剂,其缀合物,组合物以及合成和使用方法

摘要

A compound of formula: embedded imagein which L is sulfur, sulfoxide, oxygen or methylene, and a compound of formula: embedded imagein which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compounds (and their conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, are non-phosphorylated, are redox-stable in vivo, are characterized by an IC50 in vivo of less than about 4.0 μM with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, have a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates.
机译:式的化合物: “嵌入式图像” 其中L是硫,亚砜,氧或亚甲基,且式为: <图像alt =“嵌入式图像” file =“ US06951915-20051004-C00002.GIF” he =“ 14.82mm” id =“ EMI-C00002” imgContent =“ chem” imgFormat =“ GIF” wi =“ 70.44mm” /> 其中(i)aa 1 是Adi,而aa 4 是Glu或(ii)aa 1 和aa 4 <是Adi,L是硫,亚砜,氧或亚甲基,其化合物(及其结合物)结合到包含SH2结构域的蛋白质中的SH2结构域上,未被磷酸化,在体内氧化还原稳定,其特征是相对于Grb2中的SH2结构域,通过体内IC 50 小于约4.0μM,并且在与Grb2的SH2结构域结合时具有转弯构象。包含如上所述的化合物和载体的缀合物,包含(i)如上所述的化合物或缀合物和(ii)载体的组合物,抑制包含SH2结构域的蛋白质中的SH2结构域结合的方法如上所述,将SH2结构域与动物中的靶蛋白结合,其中将SH2结构域与抑制靶蛋白结合的有效量的化合物或缀合物接触,以及合成此类缀合物的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号